Eli Lilly’s Anti-Inflammatory Drug for Arthritis Helps Hospitalized COVID-19 Patients Recover Faster
Initial data from clinical trials have revealed that baricitinib in combination with remdesivir met the primary endpoint of reduction of time to recovery of hospitalized COVID-19 patients in comparison with remdesivir. More...15 Sep 2020
Landmark Coronavirus Study to Trial Inhaled Imperial and Oxford COVID-19 Vaccines
A small clinical study will compare COVID-19 vaccine candidates being developed by both Imperial College London (London, UK) and the University of Oxford (Oxford, UK) by delivering the vaccines directly to the respiratory tract of human volunteers, via inhalation through the mouth. More...15 Sep 2020
Scientists Isolate Smallest Biological Molecule to Date That Completely and Specifically Neutralizes SARS-CoV-2
Scientists at the University of Pittsburgh School of Medicine (Pittsburgh, PA, USA) have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus. More...15 Sep 2020
Global Swab and Viral Transport Medium Market Growing Rapidly Due to Rising Demand from COVID-19 Pandemic
The global swab and viral transport medium market (VTM) was valued at USD 0.9 billion in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030 to reach USD 2.2 billion by 2030, driven by increased demand during the COVID-19 (coronavirus) pandemic. More...14 Sep 2020
Computer-Designed Antiviral Proteins Protect Lab-Grown Human Cells from SARS-CoV-2
Researchers from the University of Washington (UW) Medicine (Seattle, Wash., USA) have shown that computer-designed, synthetic miniproteins act as potent, stable antivirals that block coronavirus infection of cultured human cells. More...14 Sep 2020
New Study Finds COVID-19 Cytokine Storm Does Not Exist, Suggesting Anti-Cytokine Therapies Unlikely to Help
Following the measurement of several important cytokines in patients with COVID-19 and various other severe diseases, researchers have shown that COVID-19 is not characterized by a cytokine storm, which may have consequences for the treatment of these patients. More...14 Sep 2020
Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Standing Sling
Sara Flex
New
Electric Cast Saw
CC4 System
In Other News
Lower Killer T Cells Found in COVID-19 Patients Support ‘Prime and Boost’ Coronavirus Vaccine Model
China Begins Human Trial for First COVID-19 Nasal Spray Vaccine
AstraZeneca Oxford COVID-19 Vaccine Resumes Clinical Trials in UK; Launch by 2020 End Still Achievable
New Tool Monitors SARS-CoV-2 Mutations That Make It Difficult to Develop COVID-19 Vaccines and Drugs
Universal COVID-19 Antibody Test Could Identify Suitable Plasma Donors and Provide Critical Information on Coronavirus Immunity
Repurposed Hepatitis C Drugs for COVID-19 Treatment Could Break Life Cycle of Coronavirus
SARS-CoV-2 Found in 100% of Infected Patients' Stools Suggests COVID-19 Could Be a Gut Infection
Microbiologics Launches IVD Process Controls and Inactivated Whole Virus Controls for SARS-CoV-2 Testing
AstraZeneca Confirms Participant in COVID-19 Vaccine Trial Developed Rare But Serious Spinal Inflammatory Disorder
Real-Time Imaging Shows How SARS-CoV-2 Attacks Human Cells
Delayed Immune Response to SARS-CoV-2 Explain Why More Men Die from COVID-19
Researchers Warn of Post-COVID-19 Kidney Disease Epidemic Linked to SARS-CoV-2
South Korea's Celltrion to Begin Mass Production of Experimental COVID-19 Antibody Drug Ahead of EUA Approval
DiaSorin Receives FDA Clearance for Simplexa Test That Differentiates Between COVID-19, Flu and RSV
QIAGEN to Launch Rapid Portable COVID-19 Test That Can Analyze Over 30 Samples per Hour for SARS-CoV-2 Antigen
Pfizer and BioNTech Announce Preclinical Data Supporting Efficacy for Phase 2/3 COVID-19 Vaccine
AstraZeneca COVID-19 Vaccine Phase 3 Trials Halted After Suspected Adverse Reaction in UK Participant
Pfizer and BioNTech Begin Phase 2/3 Clinical Trial for COVID-19 Vaccine Candidate in Germany
COVID-19 Vaccine Makers Sign Historic Safety Pledge Upholding Integrity of Scientific Process
Avacta Launches High Performance Affimer-Based SARS-CoV-2 ELISA Laboratory Test
Korea’s Sugentech Granted FDA EUA for Gold Nanoparticle-Based Immunochromatographic COVID-19 Test
New Antiviral COVID-19 Treatment to Be Used as Nasal Spray Could Be Made Available Over the Counter
3D Models Used for Research on Reptile and Bird Lungs Can Confirm Diagnosis of COVID-19 in Patients
